ArticleMolecular medicine reports2018

Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.

Xudong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.